611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
AHA News: Women May Be More Willing Than Men to Donate OrgansDNA Sensor Can Spot When COVID Is ContagiousTrials Show COVID Vaccines Well Worth It for Cancer PatientsCDC Endorses Booster Shots for Millions of AmericansChildhood Trauma Linked With Higher Odds for Adult Neurological IllsStudy Probes Relationship Between Migraines and SleepCancer in Hispanics: Good News and BadFDA Approves Pfizer Booster Shots for Seniors, High-Risk AmericansU.S. to Buy 500 Million More COVID Vaccine Doses for Global DonationAntibodies to Early Strains of COVID May Not Fight New Variants: StudyPregnant Women Who Get COVID Vaccine Pass Antibodies to NewbornsCDC Expert Panel to Weigh In on Vaccine BoostersWhich Kids Are at Highest Risk From COVID?4 Out of 10 Adults With No Known Heart Disease Have Fatty Hearts: StudyBooster Dose of J&J COVID Vaccine Increases ImmunityPost-Stroke Rehab: There's a Sweet Spot in the TimingCommon Form of Liver Cancer on the Rise in Rural AmericaCOVID Has Killed More Americans Than the Spanish Flu Did in 1918Telemedicine Gets High Marks for Follow-Ups After SurgeryPandemic Tied to Declining Birth Rates for U.S., Much of EuropeStudy Spots People at High Risk of Severe Breakthrough COVIDReview of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: FauciDelta Variant Now Fueling 99% of U.S. COVID CasesLower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company SaysFDA Panel OKs Pfizer Booster Shot for  People 65 or Older, But Not YoungerLong-Haul COVID in Kids Typically Ends Within 3 Months: StudyPfizer, Moderna Vaccines Still Offer Good Protection Against Severe COVID: StudyTrial Into Antioxidant for Parkinson's Disease Yields Disappointing ResultsIs Flu Ready for a Comeback? Get Your ShotCommon Eye Conditions Tied to Higher Risk for DementiaDrug Might Stop Heart Trouble Linked to Sickle Cell AnemiaChild Obesity Rose Sharply During PandemicFDA Advisory Panel to Meet on COVID Booster ShotsStatin Cholesterol Drugs May Help Fight Ulcerative ColitisAHA News: Physical Activity Is Helpful After a Stroke, But How Much Is Healthy?Special 'Strategies' Can Help People With Parkinson's Walk, But Many Patients UnawareEven When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: StudyWHO Says Africa Will Get 30% of COVID Vaccines It Needs by FebruaryCOVID Vaccines for Kids Under 12 Could Come This Fall: FauciEbola Vaccine Effective in African Clinical TrialBritain OK's COVID Vaccine for Kids 12 and Older; Hopes to Avoid LockdownsIsraeli Data on COVID Boosters to Be Published This Week in Major Journal
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Huge Study Shows Masks Do Indeed Limit Coronavirus Spread

HealthDay News
by Robert Preidt and Robin Foster
Updated: Sep 3rd 2021

new article illustration

FRIDAY, Sept. 3, 2021 (HealthDay News) -- A new, huge study provides real-world proof that mask-wearing limits the spread of the coronavirus.

"I think this should basically end any scientific debate about whether masks can be effective in combating COVID at the population level," Jason Abaluck, a Yale University economist who helped lead the study, told the Washington Post.

He called the findings "a nail in the coffin" of arguments against masks.

Abaluck and colleagues tracked more than 340,000 adults across 600 villages in rural Bangladesh, making this the largest randomized study on the effectiveness of masks at limiting the spread of the virus.

After being encouraged to wear masks, mask-wearing among the participants increased by 28.8 percentage points, resulting in a 9.3% reduction in confirmed symptomatic COVID-19 infections and a further 11.9% reduction in COVID-19 symptoms, the Post reported.

The findings do not mean that masks were only 9.3% effective, the researchers emphasized.

"I think a big error would be to read this study and to say, 'Oh, masks can only prevent 10% of symptomatic infections,'" Abaluck told the Post.

It's likely the number would be several times higher if masking were universal, he said.

Mask-wearing had been mandated in Bangladesh since March 2020, but use of masks is limited. The researchers found they increased mask-wearing in the intervention group from 13 percent to 42 percent — an increase of 28.8 percentage points.

The study, which was published on a preprint server and is under peer review with the journal Science, may make the most convincing case yet for mask use, according to some experts.

"This is an incredibly challenging but important study to pull off," Megan Ranney, an emergency medicine physician and professor at Brown University, told the Post. "Anti-mask people keep saying, 'Where's the randomized controlled trial?' Well, here you go."

"It's not just modeling or looking back at studies," Lawrence Gostin, faculty director of the O'Neill Institute for National and Global Health Law at Georgetown University, told the Post. "This is the gold standard of scientific knowledge."

"I see no reason why the interaction between the mask and the virus will behave any differently in rural Bangladesh or rural Kansas or urban New York or San Francisco," Gostin added. "The biology is the same."

More information

Visit the U.S. Centers for Disease Control and Prevention for more on masks.


SOURCE: Washington Post